← FDA Drug Approvals (Drugs@FDA)

LORATADINE

NDA · New Drug Application · Sponsor: PERRIGO · Approved 2004-06-24

Drug application

FDA Application #
NDA021512
Application type
New Drug Application
Brand name
LORATADINE
Generic name
Loratadine
Active ingredients
LORATADINE
Dosage form
TABLET
Route
ORAL
Marketing status
Discontinued
Sponsor
PERRIGO
First approval
2004-06-24

Source

Authoritative
Drugs@FDA application overview
Machine
JSON-LD · Markdown